Non‐steroidal anti‐inflammatory drugs and upper gastrointestinal bleeding, a post‐marketing surveillance case‐control study
Authors:
- 1 March 1992
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 1 (2) , 65-72
Abstract
A post‐marketing surveillance case‐control study was set up and applied in an Italian hospital network to quantify the risk of upper gastrointestinal bleeding (UGB) and exposure to non‐steroidal anti‐inflammatory drugs (NSAIDs). During the period of study 441 cases of UGB and 1323 controls were recruited. The odds ratios associated with NSAIDs use were estimated for intake occurring over two different periods of time prior to hospital admission (i.e. during the preceding week and month). A strong association emerged for aspirin intake, both in the week (ORMLR = 11.2; 95% CI 7.8–16.9) and in the month (ORMLR = 6.9; 95% CI 4.6–10.2) preceding hospital admission. A significant increase in the risk of UGB and use of diclofenac, naproxen and ibuprofen, and indomethacin was also found in the two exposure periods considered, while for piroxicam a significant association was only apparent in the analysis of 1‐month exposure. As expected, paracetamol and pyrazolone derivatives were not associated with UGB. This pilot experience has shown the feasibility of setting up a multicentre post‐marketing surveillance programme and of establishing a network for drug monitoring within the Italian National Health Service, capable of providing a thorough evaluation of the benefit/risk profile of drugs.Keywords
This publication has 34 references indexed in Scilit:
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- The Gastrointestinal Side Effects of the Nonsteroidal Anti‐Inflammatory DrugsThe Journal of Clinical Pharmacology, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988
- Repeat prescribing of non-steroidal anti-inflammatory drugs excluding aspirin: how careful are we?BMJ, 1987
- Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--2.BMJ, 1986
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCERThe Lancet, 1986
- Pyrazolone DerivativesDrugs, 1986
- Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.Gut, 1985
- Aspirin and gastrointestinal haemorrhage: A methodologic assessmentJournal of Chronic Diseases, 1985